Poxel S.A.

Poxel S.A.verified

PXXLF

Price:

$0.25

Market Cap:

$12.38M

Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is Imeglimin, an oral drug candidate, which completed Phase III clinical development stage in Japan, as well as in Phase III in the United States and Europe for the treatment of type 2 diabetes that improves pancreatic beta cell function, reduces insulin resistance, and decreases cardiovascular and metabolic disease risk factors, such as heightened blood lipid levels and excess body weight. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats c...[Read more]

Industry

Biotechnology

IPO Date

2017-01-06

Stock Exchange

OTC

Ticker

PXXLF

The Enterprise Value as of December 2025 (TTM) for Poxel S.A. (PXXLF) is 57.07M

According to Poxel S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 57.07M. This represents a change of -7.21% compared to the average of 61.50M of the last 4 quarters.

Poxel S.A. (PXXLF) Historical Enterprise Value (quarterly & annually)

How has PXXLF Enterprise Value performed in the past?

The mean historical Enterprise Value of Poxel S.A. over the last ten years is 129.55M. The current 57.07M Enterprise Value has changed 4.31% with respect to the historical average. Over the past ten years (40 quarters), PXXLF's Enterprise Value was at its highest in in the December 2019 quarter at 287.01M. The Enterprise Value was at its lowest in in the June 2011 quarter at 0.

Quarterly (TTM)
Annual

Average

129.55M

Median

111.49M

Minimum

57.71M

Maximum

286.87M

Poxel S.A. (PXXLF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Poxel S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 288.21%

Maximum Annual Enterprise Value = 286.87M

Minimum Annual Increase = -59.83%

Minimum Annual Enterprise Value = 57.71M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202365.96M14.29%
202257.71M-59.83%
2021143.66M-9.36%
2020158.50M-44.75%
2019286.87M288.21%
201873.90M-26.94%
2017101.14M-0.98%
2016102.14M-44.71%
2015184.72M52.85%
2014120.85M-15.39%

Poxel S.A. (PXXLF) Average Enterprise Value

How has PXXLF Enterprise Value performed in the past?

The current Enterprise Value of Poxel S.A. (PXXLF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

89.11M

5-year avg

142.54M

10-year avg

129.55M

Poxel S.A. (PXXLF) Enterprise Value vs. Peers

How is PXXLF’s Enterprise Value compared to its peers?

Poxel S.A.’s Enterprise Value is greater than Eiger BioPharmaceuticals, Inc. (28.35M), greater than Ceapro Inc. (-5906285.00), greater than Noxopharm Limited (28.10M), greater than Rapid Dose Therapeutics Corp. (26.58M), greater than Progressive Care, Inc. (7.25M), less than Titan Medical Inc. (86.13M), greater than Bionomics Limited (-5622531.00), greater than Living Cell Technologies Limited (21.43M), less than Sorrento Therapeutics, Inc. (112.78M), less than American Hemp Ventures, Inc. (0),

Build a custom stock screener for Poxel S.A. (PXXLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Poxel S.A. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Poxel S.A. (PXXLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Poxel S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Poxel S.A.'s Enterprise Value?

What is the highest Enterprise Value for Poxel S.A. (PXXLF)?

What is the 3-year average Enterprise Value for Poxel S.A. (PXXLF)?

What is the 5-year average Enterprise Value for Poxel S.A. (PXXLF)?

How does the current Enterprise Value for Poxel S.A. (PXXLF) compare to its historical average?